Biotechnology in South Korea

Cellgentek Co., Ltd

We create the most optimal bioimaging instrument with brilliant ideas.

11 to 50 staff

Atg Lifetech

ATG Lifetech Inc. is a cutting-edge biotechnology company specializing in new drug development and single-cell RNA-seq technology. The company is composed of experts dedicated to advancing scientific research and developing innovative solutions in biotechnology and medicine. ATG Lifetech is renowned for its high-quality oligonucleotide libraries and next-generation sequencing (NGS) technologies, which are essential for various applications, including transcriptome-wide analysis. The company is also actively engaged in Organ-on-a-Chip research, contributing significantly to the study of complex biological systems. ATG Lifetech’s work in this area includes comprehensive data analysis and the development of robust methodologies for low-input samples, such as organoid and Organ-on-a-Chip systems.

11 to 50 staff

Biovit Co., Ltd

As a biotech startup company, BIOVIT aims to create a safer and cleaner world with the use of outstanding biotechnology. BV Peptide Stabilization Platform (PSP) is a technology that utilizes pure bio materials to increase the efficacy and stability of peptides by a large margin. BIOVIT’s PSP technology emphasizes in three things: 1) Safety on human health, selectively killing only pathogens; 2) Outstanding efficiency and stability, and 3) Significant versatility in adhesive properties, making it easy to apply on various fields. BIOVIT, with the use of biotechnology, is giving all their efforts to solve infection issues. Starting with the application of antimicrobial proteins on routine objects and surfaces, then ultimately reaching out as medical product, BIOVIT aims to continue improving their proteins. If you want more information about the PSP technology and BIOVIT products, please visit or send us your inquiries to biovit@biovit.co.kr

1 to 10 staff

Bluecore Company Co., Ltd

Late Runner must be Better. Our new Aesthetic & medical Laser devices (Q-switched Nd:YAG, Er:YAG, CO2, and PICO) are ready. Want you to see what the better is?

11 to 50 staff

Danagreen

DaNAgreen Co, Ltd. is a Seoul-based biotechnology company founded in 2017. Using our patented protein crosslinking technology, we produce scaffolds that allow cells to culture in 3D. Our proprietary Protinet scaffold will be a key component in the production of cultured meat.

11 to 50 staff

Medinno

Medinno Inc. has been striving to develop cell therapeutics for brain diseases for over 15 years to give hope to numerous patients and families suffering from brain diseases.

11 to 50 staff

Alteogen

Alteogen is a leading biopharmaceutical company with a robust pipeline of next-generation biologics featuring enhanced efficacy, enabled by its proprietary platform technologies. Founded in 2008, the company is listed on the KOSDAQ stock exchange (KRX:196170). Alteogen’s most distinguished platform, Hybrozyme™, is a novel human hyaluronidase technology that enhances the absorption of biologic drugs administered via subcutaneous injection. This proprietary hyaluronidase demonstrates improved enzymatic activity and thermal stability compared to existing alternatives. Another key innovation, NexP™ fusion technology, is designed to extend the half-life of therapeutic proteins and peptides in the human body. It is currently applied to the development of long-acting biologics, including human growth hormone, exenatide (for diabetes), and Factor VIIa (for hemophilia). The company’s proprietary antibody-drug conjugate platform, NexMab™ ADC technology, enables targeted cancer therapies with improved efficacy and reduced side effects. Using this platform, Alteogen is developing ADC therapeutics for breast, gastric, and ovarian cancers. With extensive expertise and experience, Alteogen has also established its own high-expression cell lines, efficient upstream and downstream processes, and optimized analytical methods to support the development of monoclonal antibody biosimilars.

51 to 200 staff

Simple Planet

Simple Planet: Leading Sustainable Food Innovation Simple Planet envisions a future where sustainability and innovation converge to protect our planet. As a leading bio-food tech company based in South Korea, we specialize in developing advanced food ingredients through cell culture technology. This pioneering approach not only contributes to reducing carbon emissions but also strengthens food security and biodiversity essential in addressing climate change. Core Technologies: • Expertise in securing critical cell lines and utilizing SCDP (Suspension Cell Differentiation Development Platform). • Developed 13 specialized cell lines for cell-cultured foods from sources including cattle, poultry and fish. • Innovating mass culture processes using SIMPLE Planet SCDP technology to enhance production efficiency. • Achieved cost savings through the development of safe, serum-free edible culture media. 🥩 Key Products: • High-Protein Cell-based Meat Powder: Alternative protein sourced through animal-cell cultivation • Unsaturated Fatty Acids Animal-Fat Paste: cell-based fat with elevated unsaturated fatty acid content. • Customizable raw materials enhancing nutrition and flavor for various food and functional applications."SIMPLE planet.". Core Technologies • SCDP () •, 13 • SCDP • • 🥩 Key Products • ''/ • : • :

11 to 50 staff

Clecell Co.,ltd

CLECELL Co, Ltd. is a bio-platform company established to create a new future in the field of diagnosis and treatment through advances in the fields of tissue engineering and regenerative medicine based on the latest 3D Bioprinting technology. We are promoting the early expansion and commercialization of the field of 3D bioprinter utilization in the field of regenerative medicine through joint research with research institutes, biotechnology companies, and hospitals. Contact us for inquiries.#Artifical skin #Clecell3d #Clecell #TissueEngineering #Healthcare #Bioprinting #MedicalDevice #CellTherapy

11 to 50 staff

Curome Biosciences

CUROME BIOSCIENCES is a biotech company in South Korea. Phase 2 clinical trial for Primary Sclerosing Cholangitis(PSC) is ongoing.

11 to 50 staff

Novelty Nobility Inc

Novelty Nobility Inc. is a private clinical stage biotech company located in Pangyo, South Korea, and Boston, Massachusetts. We are currently focused on the research of novel angiogenesis targets and develop antibody-based therapeutics in ophthalmology and oncology, where angiogenesis plays a key pathogenic role. Novelty Nobility, a unique name for a biotech company, stands for what we pursue – Novel Science, Noble Management. The emblem in the middle of our logo, which shapes a drug, symbolizes our belief that a new drug is born when novel science meets noble management.

11 to 50 staff

Stemlab

StemLab is a Korean biotech company that is developing therapeutic solutions to treat diseases and injuries that have no alternative cures. In particular, it develops cells that can regenerate the central nervous system tissues based on its cell reprogramming technology that transforms somatic cells into stem cells. Stemlab’s cell reprogramming technology takes fully differentiated cells and reprograms them into neural stem cells, allowing them to obtain the stem cells necessary to create stem cell therapies. It thus avoids the ethical issues concernng embryonic stem cell research. Also, its reprogrammed neural stem cells have expansion capability comparable to neural stem cells derived from pluripotent stem cells. And since StemLab obtains somatic cells through urine, harvesting is much less invasive than using cells obtained using other invasive means. StemLab's technology is backed up with 18 patents for original technology related to stem cell treatments and has three patents for application technology, with another five pending. Its initial clinical programs will involve patients with spinal cord injury (SCI) and Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease).

11 to 50 staff

Contera Pharma

Contera Pharma discovers and develops innovative therapies to improve life for people suffering from neurological disorders.

11 to 50 staff

Mediforum Co., Ltd

11 to 50 staff

Peptron, Inc

Established in 1997, Peptron focuses on platform technology and clinical developments. Referred to as "Cozy-Cure," Peptron's highest priority is promoting and promising the best quality of life for patients with better treatment options, compliance, and price advantage. Peptron members' expertise in drug discovery and research, business development and strategic planning, drug delivery and formulation, GMP production, and Quality Control has helped develop peptide-based platform technology, SmartDepot™. SmartDepot™ brings the initial research process to the final medication development and successful commercialization phase with superior competitiveness. In line with proprietary technologies, we develop sustained-release (SR) medications to extend the release profile of the drug from weekly to monthly. Further, Peptron values global CDMO business. In the last few years, we have successfully formulated working with global companies with our in-depth expertise and resources. Peptron can work with you to achieve formulation development, regulatory approval and commercial manufacturing. Contact us: biz@peptron.co.kr

51 to 200 staff

Selecxine

Selecxine is a biopharmaceutical development company specialized in the field of immunotherapeutics. Selecxine strives to develop immunotherapeutics – a new paradigm of pharmaceuticals– through a specialized antibody development process, using an innovative platform technology of functional antibody screening and development. We endeavor to improve the survival rate and quality of life of cancer patients by developing anti-cancer immunotherapeutics that selectively stimulate the immune cells. These agents act against tumor cells through the regulation of cytokine function, which plays a key role in the enter cell activities. Based on our technology and expertise in the pharmacology and development field, we aim to provide safe and efficient therapeutics and innovative solutions for next-generation pharmaceuticals. CEO, Selecxine Inc. Jun-Young Lee

11 to 50 staff

Legochem Biosciences

LegoChem Biosciences, Inc.(LCB) is a research-based biotechnology company dedicated to the discovery, development, and commercialization of innovative medicines by leveraging our chemistry expertise to make conventional biologics more targeted and potent for the benefit of patients with diseases of highly unmet medical needs. We are advancing sustainable pipelines in therapeutic areas within antibiotics, anti-coagulants, oncology, antibody-drug conjugate (ADC), and protein-drug conjugate (PDC).

51 to 200 staff

Nexel

NEXEL Co, Ltd. spun off from Korea University in 2012 with its proprietary stem cell technology and by the end of 2017 has introducedHEPATOSIGHT-S and CARDIOSIGHT-S to the market These fully functional human cell products can currently be used for a variety of research, including drug screening and toxicity tests. During our research with the stem cell, we were lucky enough to stumble upon a molecule with a significant anti-fibrotic effect. Nexel has carried out various studies to optimize its stability, manufacturability, and efficacy by modifying its structure in collaboration with respected CROs in South Korea. The new drug candidate was named NP-011 and has 4-folds higher anti-fibrotic effect compared to its parent molecule. The primary indication for NP-011 is NASH and Liver Fibrosis, and use in other fibrotic diseases are currently being evaluated. NEXEL's goal for NP-011 is to find a partner with experience and expertise for co-development and file for IND by the end of 2019 with K-FDA. If you have any questions regarding either of NEXEL's human cells or protein therapy, please feel free to contact at support@nexel.co.kr Thank you.

11 to 50 staff

Daewoong Bio Inc

Daewoong Bio Inc. is a biotechnology company based in Hwaseong (Hyangnam), South Korea. Address: 35-9, Jeyakgogdan 4-gil, Hyangnam-eup, Hwaseong-si, Gyeonggi-do, South Korea, 18623

51 to 200 staff

St1 Corp. With An Official Brand Of Artipore

We develop, produce and sell biotechnology equipment and biomaterial products based on electrospinning device and bioprinting equipment manufacturing technology, biocompatible nanofiber manufacturing and bioprinting technology. Based on 3D cell culture equipment, we support the growth of various biomaterials industries, from development through clinical trials to commercial manufacturing according to GMP standards. In addition, based on the expertise of leading researchers in the biotechnology industry, it is managed multinationally with the organizational agility of startups. With research of 3D cell culture beyond 2D cell culture, we are making progress in life science. Accumulated technology of utilizing biocompatible material such as PCL(Polycaprolactone), collagens, etc, it enables our teams to develop various biocompatible medical devices, biomaterials. In addition, to expand our research to various fields, ST1 is actively conducting joint research with hospitals, research institutes, and universities.

11 to 50 staff

Doai Inc

We, DoAI is developing AI powered early stage of cancer diagnostic solutions, especially focusing on the early stage of pancreatic cancer diagnosis. We aim to provide affordable and effective health care benefits for everyone as using Nano-Raman & AI technology. Our vision is “Be the leading AI-enabled medical solution provider and accelerator of predictive, preventive, personalized and particularized health practice for patients”

11 to 50 staff

Mecasys

Mecasys Co. Ltd. has been a prominent and honest manufacturer in spectroscopic field for customers' needs, since 2001. Our employees have an ardor and diligence to support and service all needs of customers. Our advanced technologies with timely needs has been the base to create spectroscopic analysis instruments to provide customers as whole system such as highly precise spectrophotometer, better analysis system, on/off software, and solutions. In modern time, we are frustrated from trying to figure out why your endotoxin level are so high even though you've just disinfected, since there are much chemicals in your food, water, contaminated chemicals, and just alike. Becoming more responsible for needs to clean off chemicals, there are much ardor, time, money to have batter system to test, to measure, to analyze and so on. Mecasys gives you the solution to analyze this odds. The experience gained Mecasys in both optical design analysis and computer technology led to the production of spectrophotometric analyzer. Mecasys has been establishing good experience in the design and development of innovative instrumentation for a wide range of applications in Korea as well as overseas. Mecasys Co, Ltd. suggests better analyzing in biochemistry, pharmaceutical, educational, industrial, quality control and research laboratories n with ardor and diligence. If you have further inquiry, please contact us overseas@mecasys.co.kr.

51 to 200 staff

Ahram Biosystems, Inc

Ahram Biosystems, Inc. is a research-oriented biotechnology company that develops and commercializes innovative portable high-speed PCR devices and cell-based assay systems. Ahram Biosystems provides leading-edge scientific products and services in the areas of life science and pharmaceutical research, and healthcare applications. Founded in 2001, Ahram Biosystems holds numerous patents in the area of PCR amplification and cell based assays. Ahram Biosystems has its headquarters in Seoul, Korea and a business office in Silicon Valley, CA, USA.

11 to 50 staff

Antero Engineering

Antero is an Engineering and Consulting Services company that support customers in the Life Sciences field achieve their goals in capital investment and manufacturing by applying lean, holistic and pioneering technical solutions and project engineering principles

11 to 50 staff